To report SUSPECTED ADVERSE REACTIONS, contact Catalyst Pharmaceuticals at 1-844-347-3277 (1-844-FIRDAPSE) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
Some community protocols describe drawing the day's dose into a syringe before travel, capping the syringe, and transporting the syringe rather than the vial
Furthermore, as mentioned (Gwyer et al., 2019), BPC 157 inhibits the growth of several tumor lines and can counteract tumor cachexia (Kang et al., 2018), a point combined, as mentioned, with counteracted pro-inflammatory and pro-cachectic cytokines such as IL-6, TNF-, cancer cachexiarelated pathways expression (i.e., FoxO3a, p-AKT, p-mTOR, and P-GSK-3) (Kang et al., 2018)
REGEN has an excellent safety profile with minimal reported side effects
Compartment syndrome can develop at injection sites in leg muscles, causing numbness, blood clots and muscle spasms that result in permanent loss of function
Results from these clinical trials were promising, showing that the combination therapy was well-tolerated and effective